State Disclosures

The following information is being provided to Colorado prescribers pursuant to Colorado law HB 19-1131.

The price information provided represents the Wholesale Acquisition Costs ("WAC") as made available to the public by a third-party publisher. WAC does not reflect discounts, rebates and other reductions in price. The actual price paid by patients may differ and is dependent upon the individual patient’s insurance.

Adalimumab-aacf-Colorado-form 10-2024

Filename: Adalimumab-aacf-Colorado.pdf
Size: 133 KB
Format: pdf

Download Adalimumab aacf State Disclosure Colorado

BOMYNTRA-Colorado-form 12-2025

Filename: BOMYNTRA-Colorado.pdf
Size: 134 KB
Format: pdf

Download BOMYNTRA® State Disclosure Colorado

CONEXXENCE-Colorado-form 12-2025

Filename: Conexxence-Colorado.pdf
Size: 131 KB
Format: pdf

Download CONEXXENCE® State Disclosure Colorado

Diprivan Disclosure Form

Information for Colorado Prescribers of Diprivan

Filename: Diprivan-Colorado-form 11-2024.pdf
Size: 88 KB
Format: pdf

Download Diprivan® State Disclosure Colorado

Intralipid-Colorado-form 10-2024

Filename: Intralipid-Colorado.pdf
Size: 156 KB
Format: pdf

Download Intralipid® State Disclosure Colorado

KABIVEN-Colorado-form 10-2024

Filename: KABIVEN-Colorado.pdf
Size: 141 KB
Format: pdf

Download KABIVEN® State Disclosure Colorado

Omegaven-Colorado-form 10-2024

Filename: Omegaven-Colorado.pdf
Size: 138 KB
Format: pdf

Download Omegaven® State Disclosure Colorado

Filename: Otulfi®-Colorado.pdf
Size: 142 KB
Format: pdf

Download Otulfi® State Disclosure Colorado

Smoflipid-Colorado-form 10-2024

Filename: Smoflipid-Colorado.pdf
Size: 138 KB
Format: pdf

Download Smoflipid® State Disclosure Colorado

Stimufend-Colorado-form 10-2024

Filename: Stimufend-Colorado-form 11-2024.pdf
Size: 96 KB
Format: pdf

Download Stimufend® State Disclosure Colorado

Tyenne-Colorado-form 10-2024

Filename: Tyenne-Colorado.pdf
Size: 129 KB
Format: pdf

Download Tyenne® State Disclosure Colorado

Information for Connecticut Prescribers of Prescription Drugs

Connecticut law HB 6669 requires the disclosure of the list price of a legend drug when a pharmaceutical representative provides information concerning such legend drug to prescribing practitioners or pharmacists, based on the dose and quantity of such legend drug as described in the medication package insert.